Navidea Biopharmaceuticals Inc
OTC:NAVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Navidea Biopharmaceuticals Inc
OTC:NAVB
|
US |
|
N
|
Nelcast Ltd
NSE:NELCAST
|
IN |
|
R
|
Ratchthani Leasing PCL
SET:THANI
|
TH |
|
Banc of California Inc
NYSE:BANC
|
US |
|
S
|
Siam Steel International PCL
SET:SIAM
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NAVB's stock price target?
Not Available
NAVB doesn't have any price targets made by Wall Street professionals.
What is Navidea Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
261%
For the last 8 years the
compound annual growth rate for
Navidea Biopharmaceuticals Inc's revenue is
-43%.
The projected
CAGR
for the next 2 years is
261%.